Growth factors reduce the need for blood transfusion Newsletter Article 14 February 2013 Pages: 2 - 2
Growth factors allow dose escalation in cancer treatment Sean Henahan Newsletter Article 14 February 2013 Pages: 3 - 3
Sustained release option enhances potential of renin inhibitors Newsletter Article 14 February 2013 Pages: 7 - 7
Antisense oligonucleotide prolongs survival in leukaemia Newsletter Article 14 February 2013 Pages: 7 - 7
Lipid mediators - key or marginal roles in inflammation? Stephen King Newsletter Article 14 February 2013 Pages: 8 - 9
Zalcitabine fights didanosine for a wider role in AIDS Newsletter Article 14 February 2013 Pages: 12 - 12
Continue β-blockers in high-risk patients in the first year after MI Newsletter Article 14 February 2013 Pages: 13 - 13
Which treatment strategy for locally advanced breast cancer? Lynda Wiseman Newsletter Article 14 February 2013 Pages: 14 - 14
SIGMA suggests sertraline for first choice in general practice Newsletter Article 14 February 2013 Pages: 16 - 16
Terbinafine - a replacement for older antifungals? Newsletter Article 14 February 2013 Pages: 18 - 18
Once-daily nilvadipine more tolerable than thrice-daily nifedipine Newsletter Article 14 February 2013 Pages: 21 - 21